CTRI/2023/05/053279招募中4 期
A prospective, post-market clinical data analysis in patients undergoing cardioversion ordefibrillation using Skanrays Defibrillators
试验速览
- 阶段
- 4 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Data from the subject that meets the below-mentioned criteria shall be collected.
- •? Patients with indications for defibrillation/cardioversion/pacing.
- •? Male and female subjects who weigh above 10 kg.
排除标准
- •? Unsafe conditions or surroundings for the use of Direct Current
- •? Contraindications for defibrillation
- •A A responsive patient with spontaneous breathing and a palpable pulse.
- •B Asystole or pulseless electrical activity PEA
- •? Contraindications for cardioversion - arrhythmias due to enhanced automaticity, such as
- •digitalis toxicity of digitalis-associated tachycardia, sinus tachycardia, multifocal atrial
- •tachycardia and junctional tachycardia. Catecholamine-induced arrhythmia having a
- •homogeneous depolarization state Eg CPVT, shall be excluded.
- •? Contraindications for pacing - asymptomatic subjects with a reasonably stable rhythm.
研究者
相似试验
已完成
4 期
A prospective study using the KerraCel™ dressing on multiple wound typesOncological wounds (e.g. radiation burns, cancerous wounds and surgical wounds once the cancerous tissue has been removed), traumatic wounds (e.g. abrasions and lacerations), cavity wounds (such as abdominal or thoracic) and wounds created from skin donor sitesInjury, Occupational Diseases, PoisoningISRCTN33932204KCI (United States)48
尚未招募
4 期
A study to evaluate safety and performance of Hydroxypropyl Methylcellulose Eye DropsCTRI/2024/06/069121Kilitch Healthcare India Ltd.
已完成
4 期
The purpose of the study is to evaluate safety and performance of Eye Preparations- Hypromellose plus Sodium Hyaluronate Eye Drops.CTRI/2022/07/043789STERICON PHARMA PRIVATE LIMITED54
尚未招募
4 期
A study to evaluate safety and performance of Sodium Hyaluronate Ophthalmic SolutioCTRI/2024/06/068514Kilitch Healthcare India Ltd.
已完成
4 期
The purpose of the study is to evaluate safety and performance of Eye Preparations - Sodium Chloride Eye Drop (0.75%) (Calendula extract plus Hamamelis extractCTRI/2022/07/043790STERICON PHARMA PRIVATE LIMITED72